Normal Human Electro-Oculogram
Launched by NATIONAL EYE INSTITUTE (NEI) · Nov 3, 1999
Trial Information
Current as of December 10, 2023
Completed
Keywords
Description
Electro-oculograms (EOGs) will be recorded in volunteers of different age groups with normal visual function. The fast and slow oscillations of the EOG will be studied. For the analysis of fast EOG oscillations, peak-to-peak amplitude (micro V), peak-to-trough ratio, and phase (degrees) will be measured. The analysis of slow EOG oscillations will include measurements of the ratio of light peak to dark trough (Arden ratio), implicit time (latency) of the light peak (ms), and amplitude of the dark trough (micro V).
Gender
All
Eligibility criteria
- Subjects must have best corrected visual acuity equal or better than 20/20.
- Subjects must have normal visual fields.
- Subjects must have normal color vision.
- Subjects must have a normal ophthalmological exam.
- Subjects should not be subjective to or objective evidence of visual loss.
- Subjects cannot have subjective evidence of abnormal night vision or subjective evidence of abnormal light sensitivity.
- Subjects cannot have a personal history of non-trivial ocular disease.
- Subjects cannot have a family history of hereditary ocular disease.
- Subjects cannot have current systemic disease.
- Subjects cannot currently take neuropharmacological medication.
- Subjects will not be admitted with an abnormal ophthalmological examination.
- Subjects will need the ability to cooperate with EOG recording.
Attachments
4.5 MB
4.5 MB
About company
The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Reviews (48)
All reviews come from applied patients

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum?
Discussion 0